Investors bet on speciality pharmaceuticals in China
Speciality pharmaceutical company CF PharmTech is looking to raise at least $72 million in funding and has its sights set on an IPO in the near future.
June 18, 2019
Respiratory disease is a killer. Globally about 5% of all deaths are attributed to some form of lung-related illness.
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to FinanceAsia.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Questions?
See here for more information on licences and prices, or contact [email protected].